시장보고서
상품코드
2005686

정형외과용 임플란트 수탁 제조 시장 보고서 : 과거 및 예측(2021-2032년)

Global Orthopedic Implant Contract Manufacturing Market Report, History and Forecast 2021-2032

발행일: | 리서치사: 구분자 QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 3,350 금액 안내 화살표 ₩ 5,026,000
PDF (Multi User License) help
PDF, Excel 보고서를 동일 기업내 10명까지 이용하실 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF, Excel, Word 이용 범위와 동일합니다.
US $ 5,025 금액 안내 화살표 ₩ 7,539,000
PDF (Enterprise User License) help
PDF, Excel, Word 보고서를 동일 기업내 모든 구성원이 이용하실 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF, Excel, Word 이용 범위와 동일합니다.
US $ 6,700 금액 안내 화살표 ₩ 10,052,000
카드담기
※ 부가세 별도

본 보고서에서 말하는 전 세계 정형외과용 임플란트 수탁제조 시장은 정형외과 OEM 제조업체를 대상으로 임플란트 가능한 근골격계 의료기기의 산업화 및 생산을 외부에 위탁하는 것을 의미합니다. 여기에는 기계 가공, 단조, 주조, 적층 제조, 코팅, 마감 및 관련 제조 지원이 포함되지만, 단독 기구, 트레이 및 케이스, 전동 공구, 로봇 하드웨어, 기타 비이식형 정형외과 제품은 제외됩니다. 이 범위는 본 보고서에서 제시한 '이식물 전용' 시장 정의와 주요 정형외과 아웃소싱 공급업체들이 자사의 통합 제조 역량에 대해 공개적으로 설명한 내용 모두와 일치합니다.

이 보고서 시장 모델에 따르면, 세계 정형외과용 임플란트 수탁제조 시장은 2021년 46억 303만 달러에서 2025년에는 7억 667만 달러로 확대되었습니다. 2032년에는 186억 5,448만 달러에 달할 것으로 예상되며, 2021-2025년 CAGR은 13.8%, 2026-2032년 CAGR은 13.4%로 추정됩니다. 따라서 정형외과용 임플란트 프로그램 전반에 걸친 아웃소싱의 확산과 제조의 복잡성 증가에 힘입어 시장은 중기적으로 견조한 성장 궤도를 유지하고 있습니다.

지역별로는 북미가 여전히 가장 큰 시장으로 2025년 43억 6,074만 달러에서 2032년 96억 1,369만 달러로 확대될 것으로 예상되며, 유럽은 2위를 유지할 것으로 보입니다. 아시아태평양은 주요 지역 중 가장 빠르게 성장하고 있으며, 2025년 7억 4,420만 달러에서 2032년 28억 7,380만 달러로 확대될 것이며, 같은 기간 매출 점유율은 9.66%에서 15.41%로 증가할 것으로 예측됩니다. 이는 시장이 여전히 북미와 유럽에 의해 뒷받침되고 있지만, 미래의 증분 성장은 점점 더 아시아가 주도하고 있다는 것을 보여줍니다.

제조 방법별로는 2025년 '봉재 및 판재 가공'이 26억 970만 달러로 가장 큰 부문이 될 것이며, 이는 정형외과용 임플란트의 광범위한 카테고리에 적용되고 있음을 반영합니다. 그러나 구조적 성장의 원동력으로 가장 중요한 것은 '적층조형+후처리'로 2025년 14억 7,410만 달러에서 2032년 55억 9,535만 달러로 확대되며, 부문 점유율도 19.13%에서 29.99%로 증가할 것입니다. 2032년까지 적층 가공은 매출 점유율에서 봉재 및 판재 가공을 약간 앞지르며, 보다 복잡하고 부가가치가 높으며 형상 설계가 중요한 임플란트 제조 워크플로우로의 전환이 뚜렷하게 나타날 것으로 예측됩니다.

용도별로는 여전히 가장 큰 최종 시장인 대관절이 2025년 28억 1,748만 달러에서 2032년 63억 1,858만 달러로 추정됩니다. 척추 분야는 가장 매력적인 성장 분야 중 하나로 22억 2,435만 달러에서 57억 8,128만 달러로 증가할 것이며, 점유율도 28.86%에서 30.99%로 상승할 것으로 예측됩니다. 사지 및 소관절 및 스포츠 의학용 임플란트도 기반은 작지만 많은 성숙한 카테고리보다 빠르게 성장하고 있으며, 이는 아웃소싱 수요가 전통적인 재건 프로그램을 넘어선다는 것을 보여줍니다.

경쟁의 강도는 여전히 높고, 시장은 매우 세분화되어 있습니다. 2025년 기준 주요 기업으로는 Orchid Orthopedic Solutions, Marle, Cretex, Tecomet, AMETEK(Paragon Medical) 등이 있지만, 상위 5개 업체를 합해도 세계 매출의 14.19%에 불과하고, 기타 기타 공급업체에 의한 롱테일이 시장의 79.89%를 차지하고 있습니다. 전반적으로 이 보고서는 2032년까지 정형외과용 임플란트 수탁제조 시장이 양호한 성장세를 보일 것이며, OEM의 지속적인 아웃소싱, 전문 공정에 대한 수요, 적층 가공, 표면 처리 및 기타 기술적으로 진보된 임플란트 제조 분야의 부가가치 확대에 힘입어 성장세를 보일 것으로 예상하고 있습니다. 부가가치의 확대에 의해 견인될 것으로 전망하고 있습니다.

본 보고서는 정형외과용 임플란트 수탁제조 세계 시장을 정량적, 정성적 분석을 통해 종합적으로 분석하여, 독자들이 비즈니스/성장 전략을 수립하고, 시장 경쟁상황을 평가하며, 현재 시장에서의 위치를 분석하고, 정형외과용 임플란트 수탁제조에 관한 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 도움을 드리고자 합니다.

본 보고서에서는 시장에 대한 이해를 돕기 위해 경쟁 구도, 주요 경쟁사 및 각 회사 시장 순위에 대한 프로파일을 제공합니다. 또한, 기술 동향과 신제품 개발에 대해서도 논의했습니다.

이 보고서는 독자들이 업계 내 경쟁 구도와 잠재적 이익을 확대하기 위한 경쟁 환경에서의 전략을 이해하는 데 도움이 될 것입니다. 세계의 정형외과용 임플란트 수탁제조 시장 경쟁 구도에 초점을 맞추어 주요 기업의 시장 점유율, 업계 순위, 경쟁사 생태계, 시장 실적, 신제품 개발, 사업 현황, 사업 확장, 인수합병 등을 상세하게 조사하여 전해드립니다. 이를 통해 독자는 주요 경쟁사를 파악하고 시장의 경쟁 패턴을 깊이 이해할 수 있습니다.

시장 세분화

본 보고서는 기업별, 유형별, 용도별, 지역별 및 국가별 정형외과용 임플란트 수탁 제조 부문을 망라해, 2024년을 기준연도으로서 과거 및 예측 기간(2021-2026년,2027-2032년) 시장 규모와 CAGR을 제공합니다. 또한 각 부문 잠재적인 매출 기회를 분명히 해, 이 시장 매력적인 투자 제안 매트릭스에 대해 해설했습니다.

기업별

  • Marle
  • Tecomet
  • AMETEK(Paragon Medical)
  • Lincotek
  • Orchid Orthopedic Solutions
  • Micropulse
  • Precera Medical
  • Cretex
  • Croom Medical
  • Acrotec
  • DeGood
  • Avalign Technologies
  • Elos Medtech
  • Straits Orthopaedics

유형별 부문

  • 봉 및 판재 가공
  • 단조 + 가공
  • 주조 + 가공
  • 적층 제조 + 후처리
  • 성형, 압축 성형 및 소결
  • 기타

용도별 부문

  • 대형 접합부
  • 외상
  • 척추
  • 사지 및 소관절
  • 스포츠 의학 임플란트
  • 기타

지역별

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 한국
    • 태국
    • 호주
    • 기타
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스위스
    • 벨기에
    • 기타
  • 라틴아메리카
    • 브라질
    • 아르헨티나
    • 콜롬비아
    • 칠레
    • 페루
    • 기타
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카공화국
    • 오만
    • 카타르
    • 기타
LSH

The global orthopedic implant contract manufacturing market in this report is defined as the outsourced industrialization and production of implantable musculoskeletal devices for orthopedic OEMs, including machining, forging, casting, additive manufacturing, coating, finishing, and related manufacturing support, while excluding standalone instruments, trays and cases, powered tools, robotics hardware, and other non-implant orthopedic products. This scope is consistent with both the report's implant-only market definition and the way major orthopedic outsourcing suppliers publicly describe their integrated manufacturing capabilities.

Based on the report's market model, the global orthopedic implant contract manufacturing market increased from US$4,603.03 million in 2021 to US$7,706.67 million in 2025, and is forecast to reach US$18,654.48 million by 2032, representing a 13.8% CAGR in 2021-2025 and 13.4% CAGR in 2026-2032. The market therefore remains on a strong medium-term growth trajectory, supported by expanding outsourcing penetration and rising manufacturing complexity across orthopedic implant programs.

From a regional perspective, North America remains the largest market, rising from US$4,360.74 million in 2025 to US$9,613.69 million by 2032, while Europe remains the second-largest regional market. Asia-Pacific is the fastest-growing major region, expanding from US$744.20 million in 2025 to US$2,873.80 million in 2032, with its revenue share increasing from 9.66% to 15.41% over the same period. This indicates that while the market remains anchored in North America and Europe, future incremental growth is becoming increasingly Asia-led.

By manufacturing route, Bar & Plate Machining is the largest segment in 2025 at US$2,609.70 million, reflecting its broad applicability across orthopedic implant categories. However, Additive Manufacturing + Post-processing is the most important structural growth engine, rising from US$1,474.10 million in 2025 to US$5,595.35 million in 2032, with segment share increasing from 19.13% to 29.99%. By 2032, additive manufacturing slightly surpasses Bar & Plate Machining in revenue share, indicating a clear shift toward more complex, higher-value, geometry-intensive implant manufacturing workflows.

By application, Large Joints remain the largest end market, growing from US$2,817.48 million in 2025 to US$6,318.58 million in 2032. Spine is the second-largest segment and one of the most attractive growth areas, increasing from US$2,224.35 million to US$5,781.28 million, while its share rises from 28.86% to 30.99%. Extremities & Small Joints and Sports Medicine Implantables also grow faster than many mature categories from smaller bases, indicating that outsourcing demand is broadening beyond traditional reconstruction programs.

Competitive intensity remains high and the market is notably fragmented. In 2025, the leading companies include Orchid Orthopedic Solutions, Marle, Cretex, Tecomet, and AMETEK (Paragon Medical), but the top five together account for only 14.19% of global revenue, while the long tail of other suppliers represents 79.89% of the market. Overall, the report suggests that the orthopedic implant contract manufacturing market offers a favorable outlook through 2032, with growth driven by continued OEM outsourcing, demand for specialist processes, and increasing value capture in additive, surface-engineering, and other technically demanding implant manufacturing segments.

This report aims to provide a comprehensive presentation of the global market for Orthopedic Implant Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orthopedic Implant Contract Manufacturing.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orthopedic Implant Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the Orthopedic Implant Contract Manufacturing segments by company, by Type, by Application, by region and country, and provides market size and CAGR for the history and forecast period (2021-2026, 2027-2032), considering 2024 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

  • Marle
  • Tecomet
  • AMETEK (Paragon Medical)
  • Lincotek
  • Orchid Orthopedic Solutions
  • Micropulse
  • Precera Medical
  • Cretex
  • Croom Medical
  • Acrotec
  • DeGood
  • Avalign Technologies
  • Elos Medtech
  • Straits Orthopaedics

Segment by Type

  • Bar & Plate Machining
  • Forging + Machining
  • Casting + Machining
  • Additive Manufacturing + Post-processing
  • Molding, Compression & Sintering
  • Other

Segment by Application

  • Large Joints
  • Trauma
  • Spine
  • Extremities & Small Joints
  • Sports Medicine Implantables
  • Others

By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Thailand
    • Australia
    • Other
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Belgium
    • Other
  • Latin America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Other
  • Middle East & Africa
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Oman
    • Qatar
    • Other

Chapter Outline

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2026, 2027-2032). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter Four: Detailed analysis of Orthopedic Implant Contract Manufacturing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.

Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Research Finding/Conclusion

Table of Contents

1 MARKET OVERVIEW OF ORTHOPEDIC IMPLANT CONTRACT MANUFACTURING

  • 1.1 Orthopedic Implant Contract Manufacturing Market Overview
    • 1.1.1 Orthopedic Implant Contract Manufacturing Product Scope
    • 1.1.2 Orthopedic Implant Contract Manufacturing Market Status and Outlook
  • 1.2 Global Orthopedic Implant Contract Manufacturing Market Size Overview by Region 2021 VS 2025 VS 2032
  • 1.3 Global Orthopedic Implant Contract Manufacturing Market Size by Region (2021-2032)
    • 1.3.1 Global Orthopedic Implant Contract Manufacturing Historic Market Size by Region (2021-2026)
    • 1.3.2 Global Orthopedic Implant Contract Manufacturing Market Size Forecast by Region (2027-2032)
  • 1.4 Key Regions Orthopedic Implant Contract Manufacturing Market Size (2021-2032)
    • 1.4.1 North America Orthopedic Implant Contract Manufacturing Market Size (2021-2032)
    • 1.4.2 Europe Orthopedic Implant Contract Manufacturing Market Size (2021-2032)
    • 1.4.3 Asia-Pacific Orthopedic Implant Contract Manufacturing Market Size (2021-2032)
    • 1.4.4 Latin America Orthopedic Implant Contract Manufacturing Market Size (2021-2032)
    • 1.4.5 Middle East & Africa Orthopedic Implant Contract Manufacturing Market Size (2021-2032)

2 ORTHOPEDIC IMPLANT CONTRACT MANUFACTURING MARKET BY TYPE

  • 2.1 Introduction
    • 2.1.1 Bar & Plate Machining
    • 2.1.2 Forging + Machining
    • 2.1.3 Casting + Machining
    • 2.1.4 Additive Manufacturing + Post-processing
    • 2.1.5 Molding, Compression & Sintering
    • 2.1.6 Others
  • 2.2 Global Orthopedic Implant Contract Manufacturing Market Size by Type: 2021 VS 2025 VS 2032
    • 2.2.1 Global Orthopedic Implant Contract Manufacturing Historic Market Size by Type (2021-2026)
    • 2.2.2 Global Orthopedic Implant Contract Manufacturing Forecasted Market Size by Type (2027-2032)

3 ORTHOPEDIC IMPLANT CONTRACT MANUFACTURING MARKET OVERVIEW BY APPLICATION

  • 3.1 Introduction
    • 3.1.1 Large Joints
    • 3.1.2 Trauma
    • 3.1.3 Spine
    • 3.1.4 Extremities & Small Joints
    • 3.1.5 Sports Medicine Implantables
    • 3.1.6 Others
  • 3.2 Global Orthopedic Implant Contract Manufacturing Market Size by Application: 2021 VS 2025 VS 2032
    • 3.2.1 Global Orthopedic Implant Contract Manufacturing Historic Revenue by Application (2021-2026)
    • 3.2.2 Global Orthopedic Implant Contract Manufacturing Forecasted Revenue by Application (2027-2032)

4 ORTHOPEDIC IMPLANT CONTRACT MANUFACTURING COMPETITION ANALYSIS BY PLAYERS

  • 4.1 Global Orthopedic Implant Contract Manufacturing Market Size by Players (2021-2026)
  • 4.2 Global Top Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orthopedic Implant Contract Manufacturing as of 2024)
  • 4.3 Competitive Status
    • 4.3.1 Orthopedic Implant Contract Manufacturing Market Concentration Rate

5 COMPANY (TOP PLAYERS) PROFILES

  • 5.1 Marle (France)
    • 5.1.1 Marle Company Profile
    • 5.1.2 Marle Main Business
    • 5.1.3 Marle Orthopedic Implant Contract Manufacturing Products, Services and Solutions
    • 5.1.4 Marle Orthopedic Implant Contract Manufacturing Sales, Revenue, Price and Gross Margin (2021-2026)
    • 5.1.5 Marle Recent Developments
  • 5.2 Tecomet (United States)
    • 5.2.1 Tecomet Company Profile
    • 5.2.2 Tecomet Main Business
    • 5.2.3 Tecomet Orthopedic Implant Contract Manufacturing Products, Services and Solutions
    • 5.2.4 Tecomet Orthopedic Implant Contract Manufacturing Sales, Revenue, Price and Gross Margin (2021-2026)
    • 5.2.5 Tecomet Recent Developments
  • 5.3 AMETEK (Paragon Medical) (United States)
    • 5.3.1 AMETEK (Paragon Medical) Company Profile
    • 5.3.2 AMETEK (Paragon Medical) Main Business
    • 5.3.3 AMETEK (Paragon Medical) Orthopedic Implant Contract Manufacturing Products, Services and Solutions
    • 5.3.4 AMETEK (Paragon Medical) Orthopedic Implant Contract Manufacturing Sales, Revenue, Price and Gross Margin (2021-2026)
    • 5.3.5 AMETEK (Paragon Medical) Recent Developments
  • 5.4 Lincotek (Italy)
    • 5.4.1 Lincotek Company Profile
    • 5.4.2 Lincotek Main Business
    • 5.4.3 Lincotek Orthopedic Implant Contract Manufacturing Products, Services and Solutions
    • 5.4.4 Lincotek Orthopedic Implant Contract Manufacturing Sales, Revenue, Price and Gross Margin (2021-2026)
    • 5.4.5 Lincotek Recent Developments
  • 5.5 Orchid Orthopedic Solutions (United States)
    • 5.5.1 Orchid Orthopedic Solutions Company Profile
    • 5.5.2 Orchid Orthopedic Solutions Main Business
    • 5.5.3 Orchid Orthopedic Solutions Orthopedic Implant Contract Manufacturing Products, Services and Solutions
    • 5.5.4 Orchid Orthopedic Solutions Orthopedic Implant Contract Manufacturing Sales, Revenue, Price and Gross Margin (2021-2026)
    • 5.5.5 Orchid Orthopedic Solutions Recent Developments
  • 5.6 Micropulse (United States)
    • 5.6.1 Micropulse Company Profile
    • 5.6.2 Micropulse Main Business
    • 5.6.3 Micropulse Orthopedic Implant Contract Manufacturing Products, Services and Solutions
    • 5.6.4 Micropulse Orthopedic Implant Contract Manufacturing Sales, Revenue, Price and Gross Margin (2021-2026)
    • 5.6.5 Micropulse Recent Developments
  • 5.7 Precera Medical (United States)
    • 5.7.1 Precera Medical Company Profile
    • 5.7.2 Precera Medical Main Business
    • 5.7.3 Precera Medical Orthopedic Implant Contract Manufacturing Products, Services and Solutions
    • 5.7.4 Precera Medical Orthopedic Implant Contract Manufacturing Sales, Revenue, Price and Gross Margin (2021-2026)
    • 5.7.5 Precera Medical Recent Developments
  • 5.8 Cretex (United States)
    • 5.8.1 Cretex Company Profile
    • 5.8.2 Cretex Main Business
    • 5.8.3 Cretex Orthopedic Implant Contract Manufacturing Products, Services and Solutions
    • 5.8.4 Cretex Orthopedic Implant Contract Manufacturing Sales, Revenue, Price and Gross Margin (2021-2026)
    • 5.8.5 Cretex Recent Developments
  • 5.9 Croom Medical (Ireland)
    • 5.9.1 Croom Medical Company Profile
    • 5.9.2 Croom Medical Main Business
    • 5.9.3 Croom Medical Orthopedic Implant Contract Manufacturing Products, Services and Solutions
    • 5.9.4 Croom Medical Orthopedic Implant Contract Manufacturing Sales, Revenue, Price and Gross Margin (2021-2026)
    • 5.9.5 Croom Medical Recent Developments
  • 5.10 Acrotec (Switzerland)
    • 5.10.1 Acrotec Company Profile
    • 5.10.2 Acrotec Main Business
    • 5.10.3 Acrotec Orthopedic Implant Contract Manufacturing Products, Services and Solutions
    • 5.10.4 Acrotec Orthopedic Implant Contract Manufacturing Sales, Revenue, Price and Gross Margin (2021-2026)
    • 5.10.5 Acrotec Recent Developments
  • 5.11 DeGood (United States)
    • 5.11.1 DeGood Company Profile
    • 5.11.2 DeGood Main Business
    • 5.11.3 DeGood Orthopedic Implant Contract Manufacturing Products, Services and Solutions
    • 5.11.4 DeGood Orthopedic Implant Contract Manufacturing Sales, Revenue, Price and Gross Margin (2021-2026)
    • 5.11.5 DeGood Recent Developments
  • 5.12 Avalign Technologies (United States)
    • 5.12.1 Avalign Technologies Company Profile
    • 5.12.2 Avalign Technologies Main Business
    • 5.12.3 Avalign Technologies Orthopedic Implant Contract Manufacturing Products, Services and Solutions
    • 5.12.4 Avalign Technologies Orthopedic Implant Contract Manufacturing Sales, Revenue, Price and Gross Margin (2021-2026)
    • 5.12.5 Avalign Technologies Recent Developments
  • 5.13 Elos Medtech (Sweden)
    • 5.13.1 Elos Medtech Company Profile
    • 5.13.2 Elos Medtech Main Business
    • 5.13.3 Elos Medtech Orthopedic Implant Contract Manufacturing Products, Services and Solutions
    • 5.13.4 Elos Medtech Orthopedic Implant Contract Manufacturing Sales, Revenue, Price and Gross Margin (2021-2026)
    • 5.13.5 Elos Medtech Recent Developments
  • 5.14 Straits Orthopaedics (Malaysia)
    • 5.14.1 Straits Orthopaedics Company Profile
    • 5.14.2 Straits Orthopaedics Main Business
    • 5.14.3 Straits Orthopaedics Orthopedic Implant Contract Manufacturing Products, Services and Solutions
    • 5.14.4 Straits Orthopaedics Orthopedic Implant Contract Manufacturing Sales, Revenue, Price and Gross Margin (2021-2026)
    • 5.14.5 Straits Orthopaedics Recent Developments

6 NORTH AMERICA

  • 6.1 North America Orthopedic Implant Contract Manufacturing Market Size by Country (2021-2032)
  • 6.2 United States
  • 6.3 Canada
  • 6.4 Mexico

7 EUROPE

  • 7.1 Europe Orthopedic Implant Contract Manufacturing Market Size by Country (2021-2032)
  • 7.2 Germany
  • 7.3 France
  • 7.4 U.K.
  • 7.5 Italy
  • 7.6 Spain
  • 7.7 Netherlands
  • 7.8 Switzerland

8 ASIA-PACIFIC

  • 8.1 Japan
  • 8.2 China
  • 8.3 South Korea
  • 8.4 India
  • 8.5 Thailand
  • 8.6 Australia

9 LATIN AMERICA

  • 9.1 Latin America Orthopedic Implant Contract Manufacturing Market Size by Country (2021-2032)
  • 9.2 Brazil
  • 9.3 Argentina
  • 9.4 Colombia
  • 9.5 Chile
  • 9.6 Peru

10 MIDDLE EAST & AFRICA

  • 10.1 Middle East & Africa Orthopedic Implant Contract Manufacturing Market Size by Country
  • 10.2 Saudi Arabia
  • 10.3 UAE
  • 10.4 South Africa
  • 10.5 Oman

11 ORTHOPEDIC IMPLANT CONTRACT MANUFACTURING MARKET DYNAMICS

  • 11.1 Orthopedic Implant Contract Manufacturing Industry Trends
  • 11.2 Orthopedic Implant Contract Manufacturing Market Drivers
  • 11.3 Orthopedic Implant Contract Manufacturing Market Challenges
  • 11.4 Orthopedic Implant Contract Manufacturing Market Restraints

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

  • 13.1 Methodology/Research Approach
    • 13.1.1 Research Programs/Design
    • 13.1.2 Market Size Estimation
    • 13.1.3 Market Breakdown and Data Triangulation
  • 13.2 Data Source
    • 13.2.1 Secondary Sources
    • 13.2.2 Primary Sources
  • 13.3 Author Details
  • 13.4 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제